Opportunity Overview
SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026.
SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.
SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.
SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.
SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.
SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
This is one of 124 active United States Pharmaceuticals opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | DLA Troop Support |
|---|---|
| Country | United States |
| Category | Pharmaceuticals |
| Estimated value | $16.7M |
| NAICS | 325412 |
| PSC | 6505 |
| Published | November 25, 2025 |
| Procurement stage | Request for Proposal (RFP) |
| Response due | December 07, 2026 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 09, 2026 |
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
Related Opportunities in United States
See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Pharmaceuticals intelligence report in your inbox
A personalized report on United States Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.